MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 100 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $341,000 | +21.8% | 134,500 | -2.1% | 0.01% | -20.0% |
| Q1 2020 | $280,000 | -5.4% | 137,400 | 0.0% | 0.02% | +50.0% |
| Q4 2019 | $296,000 | +18.4% | 137,400 | -15.4% | 0.01% | -28.6% |
| Q3 2019 | $250,000 | -89.0% | 162,400 | -70.2% | 0.01% | -87.7% |
| Q2 2019 | $2,264,000 | +35.3% | 545,200 | +36.3% | 0.11% | +22.6% |
| Q1 2019 | $1,673,000 | +198.8% | 400,000 | +104.8% | 0.09% | +106.7% |
| Q4 2018 | $560,000 | -70.3% | 195,300 | +3.6% | 0.04% | -56.7% |
| Q3 2018 | $1,885,000 | – | 188,500 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|